In a historic 14-to-2 vote the FDA has approved Janssen Pharmaceuticals new medication, Spravato, for clinical depression.
Former CEO of pharmaceutical company, Insys, pleaded guilty to bribing doctors to prescribe opioids. Michael Babich could serve 25 years in prison.
In the final month of 2018, the CDC has released a report of the drugs that have been involved in the most deaths from 2011 to 2016.
Back in May of 2018, the FDA approved Lucemyra, a new medication to treat the symptoms of opioid withdrawal. It is available as of August of 2018.
Back in June, the FDA approved Epidiolex as the first marijuana-based medication in the United States. As of November, it is available across the U.S.
Despite the ongoing opioid epidemic, the FDA has approved Dsuvia, a synthetic opioid that is 10 times more potent than fentanyl.
On October 3rd, 2018, the Senate passed an opioid package that contained several bills that have all faced contention in the past.
Back in April, we warned of a growing synthetic marijuana outbreak. Now, another strain has struck in Connecticut and caused 100 overdoses.